The North Star Ambulatory Assessment (NSAA) is a standardized, clinician-administered tool designed to evaluate motor performance in ambulant boys with Duchenne muscular dystrophy (DMD). Developed by the North Star Clinical Network for Neuromuscular Diseases, it provides a reliable way to track disease progression and assess treatment outcomes in both clinical practice and research settings.
Duchenne muscular dystrophy is a progressive neuromuscular disorder caused by mutations in the DMD gene, leading to the absence of dystrophin — a protein critical for muscle stability. Over time, this results in muscle weakness, loss of ambulation, and functional decline. The North Star Ambulatory Assessment (NSAA) helps quantify this progression through a set of measurable motor tasks.
Table of Contents
Purpose and Importance of the NSAA in DMD
The North Star Ambulatory Assessment serves several important roles in managing Duchenne muscular dystrophy:
- Monitoring disease progression: It provides clinicians with an objective measure of changes in functional ability over time.
- Assessing treatment efficacy: It is widely used in clinical trials to evaluate the effects of therapies such as corticosteroids, exon-skipping drugs, or gene therapy.
- Supporting clinical decisions: Regular NSAA testing helps guide decisions about interventions, physiotherapy, and adaptive equipment.
Because the NSAA focuses on ambulatory (walking) function, it is typically used in boys aged 4 to 18 years, before they lose the ability to walk independently.
Structure and Scoring of the NSAA
The North Star Ambulatory Assessment consists of 17 functional tasks that assess abilities such as standing, walking, running, and climbing. Each task is scored on a 3-point scale:
- 2 = Performs task normally
- 1 = Performs task with modification or assistance
- 0 = Unable to perform task
The maximum total score is 34, representing full motor function, while lower scores indicate greater functional impairment.
NSAA Assessed Skills
- Standing: Stand barefoot for as long and still as possible without external support.
- Walking: Walk forward for at least 10 steps with a consistent heel-to-toe gait.
- Rising from chair: Begin seated with arms crossed over chest, then stand up from the chair without uncrossing arms.
- Climbing step (right leg): Step onto a box step at least 15cm high with right (or dominant) foot.
- Climbing step (left leg): Step onto a box step at least 15cm high with left (or non-dominant) foot, joining the other.
- Gets to sitting: Lay flat on the floor with arms by side and move to a sitting position without turning towards the floor or using both hands to get up. Using one hand is permissible to achieve the top score.
- Jump: Stand on the floor with both feet together and jump as high as possible with minimal forward movement.
- Run: Run as fast as possible for about 32 feet. To achieve the highest score, both feet must clear the ground when running.
- Standing on right leg: Stand on right leg, with arms down, for as long as possible.
- Stand on left leg: Stand on left leg, with arms down, for as long as possible.
- Descend box step (right leg): Facing forward, step down from the box with right (or dominant) foot.
- Descend box step (left leg): Facing forward, step down from the box with left (or non-dominant) foot, joining the other.
- Stand on heels: Lean back onto heels for three counts while barefoot. To achieve a top score, both feet must be lifted at the same time using clear dorsiflexion (raising the foot towards the shin).
- Rise from floor: Lay flat on back and stand up as quickly as possible without rolling into a four-point kneeling or prone position (Gower’s maneuver).
- Lifting head: Lay flat on the floor with arms crossed across the chest and hands resting below the shoulder. Then, lift head, touching chin to chest, while keeping arms folded.
- Hopping on right leg: Stand on right leg and hop one-legged without landing on both feet.
- Hopping on left leg: Stand on left leg and hop one-legged without landing on both feet
The test is quick to administer (usually 10–15 minutes) and requires minimal equipment, making it practical for routine clinic visits.
Interpreting NSAA Scores
North Star Ambulatory Assessment (NSAA) scores tend to follow a predictable trajectory in Duchenne muscular dystrophy:
- Early childhood (ages 4–7): Scores generally increase as motor skills develop.
- Mid-childhood (ages 7–10): Scores plateau, reflecting a balance between motor learning and muscle weakness.
- Late childhood (ages 10+): Scores decline as progressive muscle degeneration leads to loss of specific abilities.
Tracking NSAA changes over time helps clinicians detect clinically meaningful differences (CMDs) — typically a change of ≥2 points is considered significant in clinical trials. Watch Video: Assessing Motor Function in Duchenne
Use of the NSAA in Clinical Trials
The NSAA is a primary or secondary endpoint in many Duchenne clinical trials. It provides an objective and reproducible measure of motor function that correlates strongly with other outcomes, such as the 6-Minute Walk Distance (6MWD) and timed function tests (e.g., time to stand or time to climb stairs).
Because it captures functional tasks relevant to daily life, it reflects improvements that are meaningful to patients and families, making it highly valuable in the regulatory evaluation of new therapies. Read More: How Does My Child Participate in Clinical Trials for Duchenne?
Limitations of the NSAA
While the North Star Ambulatory Assessment (NSAA) is a powerful assessment tool, it has some limitations:
- It applies only to ambulant patients — non-ambulant boys require other scales such as the Performance of Upper Limb (PUL) test.
- The scoring system, though objective, may show variability between raters, emphasizing the need for trained physiotherapists.
- Environmental factors and motivation can influence performance on test days.
Despite these, the NSAA remains the gold standard for assessing ambulatory function in Duchenne muscular dystrophy.
North Star Ambulatory Assessment (NSAA): Questions and Answers
What is the North Star Ambulatory Assessment (NSAA)?
The North Star Ambulatory Assessment (NSAA) is a 17-item functional scale designed to measure motor abilities in ambulant (walking) boys with Duchenne Muscular Dystrophy (DMD).
It evaluates activities such as standing, walking, running, climbing stairs, and jumping, which are essential for daily mobility.
Why is the NSAA used in Duchenne Muscular Dystrophy?
The NSAA is used because it provides a quantitative measure of functional ability and disease progression in boys with DMD.
Clinicians and researchers use it to:
• To track changes in motor performance over time
• To assess the effectiveness of new treatments or therapies
• To monitor the impact of corticosteroid use and physiotherapy interventions
Who can perform the NSAA test?
The NSAA is typically performed by trained physiotherapists or clinicians who specialize in neuromuscular disorders. Proper training ensures that scoring is consistent and reliable across different evaluators and study sites.
How is the NSAA scored?
Each of the 17 items is scored as:
• 2 points – can perform the activity normally
• 1 point – can perform the activity with compensation or difficulty
• 0 points – unable to perform the activity
The maximum total score is 34, with higher scores indicating better motor function.
How long does it take to complete the NSAA?
The assessment typically takes about 10–15 minutes to complete, depending on the child’s level of cooperation and fatigue.
What does the NSAA measure specifically?
The North Star Ambulatory Assessment (NSAA) measures gross motor skills and ambulatory function — including:
• Standing balance
• Rising from the floor
• Walking and running ability
• Stair climbing
• Jumping and hopping
These tasks reflect the everyday motor abilities most affected by Duchenne Muscular Dystrophy.
At what age can the NSAA be used?
The NSAA is generally suitable for boys aged 4 to 18 years who are still ambulant. However, the test is most informative between ages 5 and 12, when motor skills typically peak and then gradually decline in DMD.
How often should the NSAA be performed?
In clinical practice and research studies, the NSAA is often performed every 6 to 12 months to monitor disease progression and treatment response.
How is the NSAA used in clinical trials for Duchenne Muscular Dystrophy?
The North Star Ambulatory Assessment (NSAA) is a primary or secondary outcome measure in many DMD clinical trials. It helps determine whether a new drug, gene therapy, or exon-skipping treatment is effective at slowing the decline in motor function.
What are the limitations of the NSAA?
While the North Star Ambulatory Assessment is a valuable tool, it has some limitations:
• It is only suitable for ambulant patients (those who can still walk).
• It may not detect subtle changes in motor function early or late in disease progression.
• Requires trained assessors for consistent results.
What happens when a boy with DMD becomes non-ambulant?
When walking ability is lost, the NSAA is no longer applicable. Clinicians then use alternative scales such as the Performance of Upper Limb (PUL) assessment to monitor arm and upper body function.
Can the NSAA predict loss of ambulation in DMD?
Yes. Declining North Star Ambulatory Assessment (NSAA) scores over time have been shown to correlate with the timing of loss of ambulation. For example, boys with NSAA scores below 18 are often at risk of losing the ability to walk within the next 2–3 years.
Is the NSAA reliable and validated?
Yes. The NSAA has been clinically validated and shows excellent inter-rater and test–retest reliability. It is widely accepted in both clinical care and international research trials for Duchenne Muscular Dystrophy.
How can families prepare their child for the NSAA test?
Parents can help by:
• Ensuring the child wears comfortable clothing and footwear
• Encouraging the child to rest before the test to avoid fatigue
• Providing reassurance to help the child perform each task confidently
Where can the NSAA form or scoring sheet be found?
The official NSAA form and detailed scoring guidelines are available through:
• The North Star Clinical Network for Neuromuscular Disorders (NSCN)
• Published clinical studies in neuromuscular journals
• Authorized clinical trial documentation
Conclusion
The North Star Ambulatory Assessment (NSAA) is a cornerstone tool for evaluating motor function in boys with Duchenne muscular dystrophy. Its simplicity, reliability, and sensitivity make it indispensable for both clinical management and research trials. By systematically tracking changes in motor ability, the NSAA enables clinicians and researchers to better understand disease progression and measure the real-world impact of emerging treatments.
Key Takeaways
- The NSAA measures ambulatory motor function in DMD through 17 tasks.
- Scores range from 0 to 34, with higher scores indicating better function.
- It’s widely used in clinical trials to monitor treatment effects.
- Regular NSAA testing supports personalized care and early intervention.
Read More: Clinical Trials for Duchenne (List of All Researches)
